Skip to content
Main Menu
Corporate
About Femasys
Who we are
Leadership
Investor Relations
Overview
News
Events & Presentations
Stock Info
Financials
Governance
Resources
Resources
Contact Us
Contact Femasys
Join Us
Healthcare Professionals
Infertility
FemaSeed
FemVue
Birth Control
Cancer Diagnosis
Patients
Infertility
FemVue
FemaSeed
Birth Control
Cancer Diagnosis
Search
Search
Category:
Media
Tech Companies Working On Contraception Face A New Landscape After Roe
Femasys innovating women’s reproductive health with minimally invasive, in-office technologies
VIDEO: President and CEO, Kathy Lee-Sepsick speaks to connecting with the audience
VIDEO: President and CEO, Kathy Lee-Sepsick at SLS
How Diversity And Motherhood Fortified Me As A Women’s Health CEO
VIDEO: Femasys KOL Event
‘Storm Of Change’ Could Propel Industry On Making Daily Oral Contraceptive Available OTC In US
U.S. abortion ruling ignites retail interest in women contraceptive makers
With Roe overturned, Femasys’ permanent contraception has increased appeal
With Roe v. Wade In Rearview, What’s Next For Women’s Health?
←
older
newer
→
Main Menu
Corporate
About Femasys
Who we are
Leadership
Investor Relations
Overview
News
Events & Presentations
Stock Info
Financials
Governance
Resources
Resources
Contact Us
Contact Femasys
Join Us
Healthcare Professionals
Infertility
FemaSeed
FemVue
Birth Control
Cancer Diagnosis
Patients
Infertility
FemVue
FemaSeed
Birth Control
Cancer Diagnosis